5UW6 image
Entry Detail
PDB ID:
5UW6
Keywords:
Title:
PCY1 in Complex with Follower Peptide and Covalent Inhibitor ZPP
Biological Source:
Source Organism:
Host Organism:
PDB Version:
Deposition Date:
2017-02-20
Release Date:
2017-05-31
Method Details:
Experimental Method:
Resolution:
3.30 Å
R-Value Free:
0.21
R-Value Work:
0.17
R-Value Observed:
0.17
Space Group:
P 1
Macromolecular Entities
Polymer Type:polypeptide(L)
Description:Peptide cyclase 1
Chain IDs:A, C (auth: B), E (auth: C), G (auth: D)
Chain Length:750
Number of Molecules:4
Biological Source:Vaccaria hispanica
Polymer Type:polypeptide(L)
Description:Presegetalin A1
Chain IDs:B (auth: E), D (auth: F), F (auth: G), H
Chain Length:6
Number of Molecules:4
Biological Source:Vaccaria hispanica
Peptide-like Molecules
PRD_000692
Primary Citation
Characterization of the macrocyclase involved in the biosynthesis of RiPP cyclic peptides in plants.
Proc. Natl. Acad. Sci. U.S.A. 114 6551 6556 (2017)
PMID: 28584123 DOI: 10.1073/pnas.1620499114

Abstact

Enzymes that can catalyze the macrocyclization of linear peptide substrates have long been sought for the production of libraries of structurally diverse scaffolds via combinatorial gene assembly as well as to afford rapid in vivo screening methods. Orbitides are plant ribosomally synthesized and posttranslationally modified peptides (RiPPs) of various sizes and topologies, several of which are shown to be biologically active. The diversity in size and sequence of orbitides suggests that the corresponding macrocyclases may be ideal catalysts for production of cyclic peptides. Here we present the biochemical characterization and crystal structures of the plant enzyme PCY1 involved in orbitide macrocyclization. These studies demonstrate how the PCY1 S9A protease fold has been adapted for transamidation, rather than hydrolysis, of acyl-enzyme intermediates to yield cyclic products. Notably, PCY1 uses an unusual strategy in which the cleaved C-terminal follower peptide from the substrate stabilizes the enzyme in a productive conformation to facilitate macrocyclization of the N-terminal fragment. The broad substrate tolerance of PCY1 can be exploited as a biotechnological tool to generate structurally diverse arrays of macrocycles, including those with nonproteinogenic elements.

Legend

Protein

Chemical

Disease

Primary Citation of related structures